Overview

Trial of Intensive Chemotherapy With or Without Volasertib in Patients With Newly Diagnosed High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Status:
Terminated

Trial end date:
2016-11-01

Target enrollment:

Participant gender:

Summary

Randomized Phase II Trial of Intensive Chemotherapy With or Without Volasertib (BI 6727) in Patients With Newly Diagnosed High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Phase:

Phase 2

Details

Lead Sponsor:

University of Ulm

Treatments:

Cytarabine
Daunorubicin
Mitoxantrone